Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii -: Novel structural features and apoptosis-inducing properties

被引:79
作者
Guérardel, Y
Maes, E
Briken, V
Chirat, F
Leroy, Y
Locht, C
Strecker, G
Kremer, L
机构
[1] Inst Pasteur, INSERM, U447, IBL,Lab Mecanismes Mol Pathogenie Microbienne, F-59019 Lille, France
[2] Univ Sci & Technol Lille, CNRS, UMR8576, Lab Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
关键词
D O I
10.1074/jbc.M305427200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although Mycobacterium kansasii has emerged as an important pathogen frequently encountered in immunocompromised patients, little is known about the mechanisms of M. kansasii pathogenicity. Lipoarabinomannan (LAM), a major mycobacterial cell wall lipoglycan, is an important virulence factor for many mycobacteria, as it modulates the host immune response. Therefore, the detailed structures of the of M. kansasii LAM (KanLAM), as well as of its biosynthetic precursor lipomannan (KanLM), were determined in a clinical strain isolated from a human immunodeficiency virus-positive patient. Structural analyses revealed that these lipoglycans possess important differences as compared with those from other mycobacterial species. KanLAM carries a mannooligosaccharide cap but is devoid of the inositol phosphate cap present in Mycobacterium smegmatis. Characterization of the mannan core of KanLM and KanLAM demonstrated the following occurrences: 1) alpha1,2-oligomannopyranosyl side chains, contrasting with the single mannopyranosyl residues substituting the mannan core in all the other structures reported so far; and 2) 5-methylthiopentose residues that were described to substitute the arabinan moiety from Mycobacterium tuberculosis LAM. With respect to the arabinan domain of KanLAM, succinyl groups were found to substitute the C-3 position on 5-arabinofuranosyl residues, reported to be linked to the C-2 of the 3,5-arabinofuranose in Mycobacterium bovis bacillus calmette-guerin LAM. Because M. kansasii has been reported to induce apoptosis, we examined the possibility of the M. kansasii lipoglycans to induce apoptosis of THP-1 cells. Our results indicate that, in contrast to KanLAM, KanLM was a potent apoptosis-inducing factor. This work underlines the diversity of LAM structures among various pathogenic mycobacterial species and also provides evidence of LM being a potential virulence factor in M. kansasii infections by inducing apoptosis.
引用
收藏
页码:36637 / 36651
页数:15
相关论文
共 57 条
[31]   Mycobacterial lipoarabinomannans:: modulators of dendritic cell function and the apoptotic response [J].
Nigou, J ;
Gilleron, M ;
Rojas, M ;
García, LF ;
Thurnher, M ;
Puzo, G .
MICROBES AND INFECTION, 2002, 4 (09) :945-953
[32]   The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guerin - Heterogeneity, structure, and role in the regulation of cytokine secretion [J].
Nigou, J ;
Gilleron, M ;
Cahuzac, B ;
Bounery, JD ;
Herold, M ;
Thurnher, M ;
Puzo, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :23094-23103
[33]   Lipoarabinomannans:: characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy [J].
Nigou, J ;
Gilleron, M ;
Puzo, G .
BIOCHEMICAL JOURNAL, 1999, 337 :453-460
[34]   Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor [J].
Nigou, J ;
Zelle-Rieser, C ;
Gilleron, M ;
Thurnher, M ;
Puzo, G .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7477-7485
[35]  
OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007
[36]   Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus [J].
Pintado, V ;
Gómez-Mampaso, E ;
Martín-Dávila, P ;
Cobo, J ;
Navas, E ;
Quereda, C ;
Fortún, J ;
Guerrero, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (08) :582-586
[37]   STRUCTURE AND ANTIGENICITY OF LIPOARABINOMANNAN FROM MYCOBACTERIUM-BOVIS BCG [J].
PRINZIS, S ;
CHATTERJEE, D ;
BRENNAN, PJ .
JOURNAL OF GENERAL MICROBIOLOGY, 1993, 139 :2649-2658
[38]   THP-1 cell apoptosis in response to mycobacterial infection [J].
Riendeau, CJ ;
Kornfeld, H .
INFECTION AND IMMUNITY, 2003, 71 (01) :254-259
[39]  
Rojas M, 1997, J IMMUNOL, V159, P1352
[40]   Mannosylated lipoarabinomannan antagonizes Mycobacterium tuberculosis-induced macrophage apoptosis by altering Ca+2-dependent cell signaling [J].
Rojas, M ;
García, LF ;
Nigou, J ;
Puzo, G ;
Olivier, M .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :240-251